Wanbury Ltd
NSE:WANBURY
Relative Value
The Relative Value of one
WANBURY
stock under the Base Case scenario is
hidden
INR.
Compared to the current market price of 269.97 INR,
Wanbury Ltd
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
WANBURY Competitors Multiples
Wanbury Ltd Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IN |
|
Wanbury Ltd
NSE:WANBURY
|
9.4B INR | 1.4 | 14.6 | 10.1 | 11.6 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
984.9B USD | 15.1 | 47.8 | 32.2 | 34.3 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
592.6B USD | 6.3 | 22 | 15.3 | 18.8 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
291.5B CHF | 4.8 | 31.3 | 13.2 | 15.4 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
235.1B GBP | 5.5 | 31.5 | 17.4 | 24.5 | |
| CH |
|
Novartis AG
SIX:NOVN
|
243.5B CHF | 5.6 | 22.5 | 13.9 | 17.8 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
306B USD | 4.7 | 16.7 | 10.4 | 12.2 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.2T DKK | 3.7 | 11.3 | 8.3 | 9.8 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
152.2B USD | 2.4 | 19.7 | 7.3 | 9.8 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
123.2B USD | 2.6 | 17.5 | 7.3 | 9 |